glp-1's GLP-1 Receptor Agonists as Treatments for Type 2 Diabetes GLP-1 Medications – Community Education

(2021a)

Effect of liraglutide, a glucagon-like peptide-1 analogue, on left ventricular function in stable chronic heart failure patients with and without diabetes (LIVE)A multicentre, double-blind, randomised, placebo-controlled trial

GLP-1 Boost+ GutMetabolic Support & Appetite Balance Save on every delivery

18 These guidelines cover the PBS restrictions, based largely on cost, to their subsidised prescription with DPP-4 inhibitors (with which there is also a shared mechanism of action and thus potential therapeutic redundancy), SGLT2 inhibitors and thiazolidinediones

Comments: 1

Insulin and glucagon-like peptide 1 receptor agonist combination therapy in type 2 diabetes: a systematic review and meta-analysis of randomized controlled trials